Ibrunat 140Mg

Ibrutinib is a type of cancer medication called a kinase inhibitor. Ibrutinib helps to slow down how quickly certain blood cancers progresses by working against cancerous B cells, a type of white blood cell. It does this by blocking Bruton’s tyrosine kinase (BTK) signaling. BTK is a protein found on B cells that instructs B cells to remain alive and multiple. Ibrutinib comes as both tablets and capsules. It was approved by the US Food and Drug Administration (FDA) in 2013 and was the first effective and selective BTK inhibitor to be approved.